ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Nomograms predicting prognosis of patients with pathological stages T1N2-3 and T3N0 gastric cancer

Wang, Yu-Fei; Yin, Xin; Fang, Tian-Yi; Wang, Yi-Min; Zhang, Dao-Xu; Zhang, Yao; Wang, Xi-Bo; Wang, Hao; Xue, Ying-Wei*哈尔滨医科大学
World Journal of Gastrointestinal Surgery2022-2-27DOI: 10.4240/wjgs.v14.i2.143
2被引8阅读
引用收藏
分享

摘要

BACKGROUND & nbsp;Patients with pathological stages T1N2-3 (pT1N2-3) and pT3N0 gastric cancer (GC) have not been routinely included in the target population for postoperative chemotherapy according to the Japanese Gastric Cancer Treatment Guideline, and their prognosis is significantly different.& nbsp;AIM & nbsp;To identify the high-risk patients after radical surgery by analyzing biomarkers and clinicopathological features and construct prognostic models for them.& nbsp;METHODS & nbsp;A total of 459 patients with pT1N2-3/pT3N0 GC were retrospectively selected for the study. The Chi-square test was used to analyze the differences in the clinicopathological features between the pT1N2-3 and pT3N0 groups. The Kaplan-Meier analysis and log-rank test were used to analyze overall survival (OS). The independent risk factors for patient prognosis were analyzed by univariate and multivariate analyses based on the Cox proportional hazards regression model. The cutoff values of continuous variables were identified by receiver operating characteristic curve. The nomogram models were constructed with R studio.& nbsp;RESULTS & nbsp;There was no statistically significant difference in OS between the pT1N2-3 and pT3N0 groups (P = 0.374). Prealbumin (P = 0.040), carcino-embryonic antigen (CEA) (P = 0.021), and metastatic lymph node ratio (mLNR) (P = 0.035) were independent risk factors for prognosis in the pT1N2-3 group. Age (P = 0.039), body mass index (BMI) (P = 0.002), and gastrectomy (P < 0.001) were independent risk factors for prognosis in the pT3N0 group. The area under the curve values of the nomogram models for predicting the 5-year prognosis of the pT1N2-3 group and pT3N0 group were 0.765 and 0.699, respectively.& nbsp;CONCLUSION & nbsp;Nomogram model combining prealbumin, CEA, and mLNR levels can be used to predict the prognosis of pT1N2-3 GC. Nomogram model combining age, BMI, and gastrectomy can be used to predict the prognosis of pT3N0 GC.

学科与关键词

关键词
Gastric cancerBiomarkerClinicopathological featureAdjuvant chemotherapyPrognosisNomogram
相关
加载中…
  • Development and Validation of Prognostic Nomograms Based on Lymph Node Ratio for Young Patients with Gastric Cancer: A SEER-Based Study
    Chen, Yi-Ru; Tian, Zhen-Yi; Wang, Mei-Qian; Sun, Mei-Ling; Wu, Jin-Zhen; Wang, Xin-Ying*TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2023, 22: 15330338231157923.
  • Nutritional Risk Index as a Prognostic Factor Predicts the Clinical Outcomes in Patients With Stage III Gastric Cancer
    Song, Haibin; Sun, Hongkai; Yang, Laishou; Gao, Hongyu; Cui, Yongkang; Yu, Chengping; Xu, Haozhi; Li, Linqiang*Frontiers in Oncology, 2022, 12: 880419.被引 3
  • Proposed Models for Prediction of Mortality in Stage-I and Stage-II Gastric Cancer and 5 Years after Radical Gastrectomy
    Fang, Tianyi; Yin, Xin; Wang, Yufei; Zhang, Lei; Zhang, Xinghai; Zhao, Xudong; Wang, Yimin; Xue, Yingwei*Journal of Oncology, 2022, 2022: 4510000.被引 6
查看全部 →

发表信息

论文状态
公开发表
期刊
World Journal of Gastrointestinal Surgery
发表日期
2022-02-27
卷期
第 14 卷, 第 2 期
页码
143-160
DOI
10.4240/wjgs.v14.i2.143
期刊等级
4区
成果收录
SCIE
资助标注
Nn10 Program of Harbin Medical University Cancer Hospital, China [Nn10 PY 2017-03]

作者

  • W

    Wang, Yu-Fei (第一作者)

    harbin med univ

  • Y

    Yin, Xin

    harbin med univ

查看全部 9 位作者收起作者
  • F

    Fang, Tian-Yi

    harbin med univ

  • W

    Wang, Yi-Min

    harbin med univ

  • Z

    Zhang, Dao-Xu

    harbin med univ

  • Z

    Zhang, Yao

    harbin med univ

  • W

    Wang, Xi-Bo

    harbin med univ

  • W

    Wang, Hao

    harbin med univ

  • X

    Xue, Ying-Wei (通讯)

    harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417